why choose us

Clinical Trials Search

Showing 17,760 of 132,963 result(s)
A Study of ASP2074 in Adults With Solid Tumors

Status: Completed

Condition: Advanced Solid Tumors

Interventions: intravenous (IV) infusion

Date: 2022-12-01

Reducing Stress-Sensitive Problems Among Pregnant Black Women With Childhood Adversity

Status: Completed

Condition: Maternal Psychological Distress

Interventions: TPI is designed to foster behavior change and health coping by enhancing knowledge, beliefs, regulation skills and abilities.
In the experimental

Date: 2022-12-01

Gender Related Coping and Survivorship for Genitourinary Cancers

Status: Completed

Condition: Bladder Cancer

Interventions: Study-Specific Patient Handouts, Treating-Provider led counseling, Women's Bladder Cancer Support Group, Women's Bladder Cancer Educational

Date: 2022-12-01

Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease

Status: Completed

Condition: Alzheimer Disease

Interventions: Ex Vivo Expanded, Autologous Adipose-Derived Stem Cells (ADSCs)

Date: 2022-12-01

Exploring the Feasibility of Centering Pregnancy With Care Navigation

Status: Completed

Condition: Premature Birth

Interventions: Centering Pregnancy is a group based prenatal care intervention.
Centering Pregnancy is an evidenced based intervention that has 10 group session

Date: 2022-12-01

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Status: Completed

Condition: Ulcerative Colitis Chronic Mild

Interventions: Probiotic

Date: 2022-12-01

An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus

Status: COMPLETED

Condition: Tinnitus

Interventions: Brexanolone IV infusion

Date: 2022-12-01

Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

Status: Completed

Condition: Solid Tumor

Interventions: Given in to the vein (IV)

Date: 2022-12-01

Pilot Mobile Medical Unit Study for I'm Fully Empowered4Her

Status: Completed

Condition: HIV Prevention

Interventions: IFE4Her consists of 2 key components: 1) An awareness-raising messaging campaign with messages about PrEP that includes posters and Peer Networkers; a

Date: 2022-12-01

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Status: Completed

Condition: Multiple Myeloma

Interventions: KTX-1001 will be administered orally, daily for 28 days.

Date: 2022-12-01